|
2025
|
Invention
|
Stromal stem cell therapeutics and methods of use.
Provided herein are stromal stem cell therape... |
|
2024
|
Invention
|
Stromal stem cells.
Stromal stem cells are prospectively isolated from human bone marrow then ex... |
|
|
Invention
|
Sdc-2 exosome compositions and methods of isolation and use.
Disclosed herein are compositions c... |
|
2023
|
Invention
|
Scd2+ stromal cells for treating diabetic kidney disease. Provided herein are compositions and me... |
|
|
Invention
|
Stromal stem cells. Stromal stem cells are prospectively isolated from human bone marrow then exp... |
|
2022
|
Invention
|
Methods of isolation and use of cd39 stromal stem cells.
Disclosed herein are methods of isolati... |
|
2020
|
Invention
|
Compositions for monocyte and macrophage polarization and methods of use.
Provided herein are me... |
|
|
Invention
|
Compositions for monocyte and macrophage polarization and methods of use. Provided herein are met... |
|
2019
|
Invention
|
Syndecan-2 compositions and methods of use. SDC2, compositions that comprise SDC2, vectors encodi... |
|
2018
|
Invention
|
Modulators of syndecan-2 and uses thereof. Modulators of syndecan-2, such as an antibody to synde... |
|
|
Invention
|
Methods of isolation and use of cd39 stromal stem cells. Disclosed herein are methods of isolatin... |
|
|
Invention
|
Cd39 stromal stem cells methods of isolation and use. Disclosed herein are methods of isolating S... |
|
|
Invention
|
Stromal stem cell therapeutics and methods of use. Provided herein are stromal stem cell therapeu... |
|
2017
|
Invention
|
Sdc-2 exosome compositions and methods of isolation and use. Disclosed herein are compositions co... |
|
2016
|
Invention
|
Modulators of syndecan-2 and uses thereof. A modulator of syndecan-2, e.g. an antibody to syndeca... |
|
2014
|
Invention
|
Medical use of syndecan-2. SDC2, compositions that comprise SDC2, vectors encoding SDC2 and compo... |
